Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses

被引:81
|
作者
Sievers, Benjamin L. [1 ]
Chakraborty, Saborni [2 ]
Xue, Yong [3 ]
Gelbart, Terri [1 ]
Gonzalez, Joseph C. [2 ,4 ]
Cassidy, Arianna G. [5 ]
Golan, Yarden [6 ,7 ]
Prahl, Mary [8 ]
Gaw, Stephanie L. [5 ]
Arunachalam, Prabhu S. [9 ]
Blish, Catherine A. [2 ,4 ,10 ]
Boyd, Scott D. [11 ,12 ,13 ]
Davis, Mark M. [9 ,12 ,14 ]
Jagannathan, Prasanna [2 ,12 ]
Nadeau, Kari C. [13 ]
Pulendran, Bali [9 ]
Singh, Upinder [2 ,12 ]
Scheuermann, Richard H. [1 ,15 ]
Frieman, Matthew B. [16 ]
Vashee, Sanjay [3 ]
Wang, Taia T. [2 ,4 ,10 ,12 ]
Tan, Gene S. [1 ,17 ]
机构
[1] J Craig Venter Inst, La Jolla, CA 92037 USA
[2] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA
[3] J Craig Venter Inst, Rockville, MD 20850 USA
[4] Stanford Univ, Program Immunol, Sch Med, Stanford, CA 94305 USA
[5] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA 94115 USA
[6] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94115 USA
[7] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94115 USA
[8] Univ Calif San Francisco, Dept Pediat, Div Pediat Infect Dis, San Francisco, CA 94115 USA
[9] Stanford Univ, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA
[10] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA
[11] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA
[12] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA
[13] Sean N Parker Ctr Allergy & Asthma Res, Dept Med, Stanford, CA 94305 USA
[14] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA
[15] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92037 USA
[16] Univ Maryland, Ctr Pathogen Res, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA
[17] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92037 USA
关键词
D O I
10.1126/scitranslmed.abn7842
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that have mutations associated with increased transmission and antibody escape have arisen over the course of the current pandemic. Although the current vaccines have largely been effective against past variants, the number of mutations found on the Omicron (B.1.1.529) spike protein appear to diminish the protection conferred by preexisting immunity. Using vesicular stomatitis virus (VSV) pseudoparticles expressing the spike protein of several SARS-CoV-2 variants, we evaluated the magnitude and breadth of the neutralizing antibody response over time in individuals after infection and in mRNA-vaccinated individuals. We observed that boosting increases the magnitude of the antibody response to wild-type (D614), Beta, Delta, and Omicron variants; however, the Omicron variant was the most resistant to neutralization. We further observed that vaccinated healthy adults had robust and broad antibody responses, whereas responses may have been reduced in vaccinated pregnant women, underscoring the importance of learning how to maximize mRNA vaccine responses in pregnant populations. Findings from this study show substantial heterogeneity in the magnitude and breadth of responses after infection and mRNA vaccination and may support the addition of more conserved viral antigens to existing SARS-CoV-2 vaccines.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Neutralizing and enhancing antibodies against SARS-CoV-2
    Yafei Liu
    Hisashi Arase
    Inflammation and Regeneration, 42
  • [22] Therapeutic Potential of Neutralizing Monoclonal Antibodies (nMAbs) against SARS-CoV-2 Omicron Variant
    Parua, Pijus
    Ghosh, Somnath
    Jana, Koushik
    Seth, Arnab
    Debnath, Biplab
    Rout, Saroj Kumar
    Sarangi, Manoj Kumar
    Dash, Rasmita
    Halder, Jitu
    Rajwar, Tushar Kanti
    Pradhan, Deepak
    Rai, Vineet Kumar
    Dash, Priyanka
    Das, Chandan
    Kar, Biswakanth
    Ghosh, Goutam
    Rath, Goutam
    CURRENT PHARMACEUTICAL DESIGN, 2025, 31 (10) : 753 - 773
  • [23] Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination
    Edara, Venkata Viswanadh
    Hudson, William H.
    Xie, Xuping
    Ahmed, Rafi
    Suthar, Mehul S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (18): : 1896 - 1898
  • [24] Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants
    Ju, Bin
    Zhang, Qi
    Wang, Ziyi
    Aw, Zhen Qin
    Chen, Peng
    Zhou, Bing
    Wang, Ruoke
    Ge, Xiangyang
    Lv, Qining
    Cheng, Lin
    Zhang, Rui
    Wong, Yi Hao
    Chen, Huixin
    Wang, Haiyan
    Shan, Sisi
    Liao, Xuejiao
    Shi, Xuanling
    Liu, Lei
    Chu, Justin Jang Hann
    Wang, Xinquan
    Zhang, Zheng
    Zhang, Linqi
    NATURE IMMUNOLOGY, 2023, 24 (04) : 690 - +
  • [25] Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
    Bo Gao
    Liheng He
    Yujie Bao
    Yingying Chen
    Guanzhu Lu
    Yu Zhang
    Yingjie Xu
    Bing Su
    Jie Xu
    Ying Wang
    Leng-Siew Yeap
    Cell Research, 2023, 33 : 258 - 261
  • [26] Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
    Gao, Bo
    He, Liheng
    Bao, Yujie
    Chen, Yingying
    Lu, Guanzhu
    Zhang, Yu
    Xu, Yingjie
    Su, Bing
    Xu, Jie
    Wang, Ying
    Yeap, Leng-Siew
    CELL RESEARCH, 2023, 33 (03) : 258 - 261
  • [27] Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants
    Bin Ju
    Qi Zhang
    Ziyi Wang
    Zhen Qin Aw
    Peng Chen
    Bing Zhou
    Ruoke Wang
    Xiangyang Ge
    Qining Lv
    Lin Cheng
    Rui Zhang
    Yi Hao Wong
    Huixin Chen
    Haiyan Wang
    Sisi Shan
    Xuejiao Liao
    Xuanling Shi
    Lei Liu
    Justin Jang Hann Chu
    Xinquan Wang
    Zheng Zhang
    Linqi Zhang
    Nature Immunology, 2023, 24 : 690 - 699
  • [28] Neutralizing SARS-CoV-2 Spike Antibodies against Omicron in Paired Samples after Two or Three Doses of mRNA Vaccine
    Debes, Amanda K.
    Xiao, Shaoming
    Egbert, Emily R.
    Caturegli, Patrizio
    Gadala, Avinash
    Colantuoni, Elizabeth
    Sitaras, Ioannis
    Pekosz, Andrew
    Milstone, Aaron M.
    MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [29] Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2
    Luo, Mengxiao
    Zhou, Biao
    Reddem, Eswar R.
    Tang, Bingjie
    Chen, Bohao
    Zhou, Runhong
    Liu, Hang
    Liu, Lihong
    Katsamba, Phinikoula S.
    Au, Ka-Kit
    Man, Hiu-On
    To, Kelvin Kai-Wang
    Yuen, Kwok-Yung
    Shapiro, Lawrence
    Dang, Shangyu
    Ho, David D.
    Chen, Zhiwei
    EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
  • [30] Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display
    Tanaka, Shiho
    Olson, C. Anders
    Barnes, Christopher O.
    Higashide, Wendy
    Gonzalez, Marcos
    Taft, Justin
    Richardson, Ashley
    Martin-Fernandez, Marta
    Bogunovic, Dusan
    Gnanapragasam, Priyanthi N. P.
    Bjorkman, Pamela J.
    Spilman, Patricia
    Niazi, Kayvan
    Rabizadeh, Shahrooz
    Soon-Shiong, Patrick
    CELL REPORTS, 2022, 38 (06):